Dare Bioscience, Inc. Letters of Credit Outstanding, Amount
Dare Bioscience, Inc. (DARE) had Letters of Credit Outstanding, Amount of $300.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Notes › Other Liabilities
us-gaap:LettersOfCreditOutstandingAmount · last filed 2023-11-09
- 2023-09-30: Letters of Credit Outstanding, Amount $300.00K.
- 2023-06-30: Letters of Credit Outstanding, Amount $300.00K.
- 2023-03-31: Letters of Credit Outstanding, Amount $35.00K.
- 2022-12-31: Letters of Credit Outstanding, Amount $35.00K.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2023-09-30 | $300.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $300.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $35.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $35.00K 10-K · filed 2023-03-30 |
| 2021-12-31 | $35.90K 10-K · filed 2022-03-31 |
| 2020-12-31 | $35.90K 10-K · filed 2021-03-30 |
| 2019-12-31 | $35.90K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |